AKT1 and Alzheimer disease: In addition, based on the relationship between PI3K/Akt signaling pathway and AD, previous studies have shown that an alkaloid BBR can reduce the Aβ levels, glial activation and cognitive impairment in the TgCRND8 mouse model by activating PI3K/Akt/GSK3 signaling pathway.